Risk Management in Hospitals

The objective of this study is to develop a risk map for blood-derived medications using the Failure Mode and Effects Analysis (FMEA) method. This method aims to improve patient safety in the hospital setting-specifically at the Monastir University Hospital in Tunisia-and to propose an action plan based on risk priority. Our approach begins with forming a multidisciplinary team and organizing brainstorming sessions. The blood-derived drug supply chain process is broken down into stages or "elementary processes" and sub-stages, ranging from procurement to waste management. We then identify the failure modes for each stage, along with their causes and consequences. We define the rating scale and its dimensions of frequency, severity, and criticality. Based on the defined scale, we calculate the criticality index for each step and analyze the risks to identify the most vulnerable steps.